down arrow

Chongqing Lummy Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000H10
CNY
5.10
-0.35 (-6.42%)

Dec 04

SHE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Chongqing Lummy Pharmaceutical Co., Ltd.
Why is Chongqing Lummy Pharmaceutical Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 0%
  • The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward
2
Poor long term growth as Net Sales has grown by an annual rate of -13.88% and Operating profit at -2.20% over the last 5 years
3
Negative results in Mar 25
  • NET PROFIT(HY) At CNY -75.16 MM has Grown at -283.27%
  • NET SALES(HY) At CNY 381 MM has Grown at -9.89%
  • ROCE(HY) Lowest at -4.93%
4
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 6.65%, its profits have fallen by -290.5%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Chongqing Lummy Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Chongqing Lummy Pharmaceutical Co., Ltd.
-6.93%
1.66
60.80%
China Shanghai Composite
14.77%
1.01
15.10%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-13.88%
EBIT Growth (5y)
-2.20%
EBIT to Interest (avg)
-8.56
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.27
Sales to Capital Employed (avg)
0.35
Tax Ratio
2.21%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.88
EV to EBIT
-20.03
EV to EBITDA
-31.50
EV to Capital Employed
2.26
EV to Sales
3.76
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-11.28%
ROE (Latest)
-6.36%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
CASH AND EQV(HY)

Highest at CNY 1,922.06 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 1.83%

-23What is not working for the Company
NET PROFIT(HY)

At CNY -75.16 MM has Grown at -283.27%

NET SALES(HY)

At CNY 381 MM has Grown at -9.89%

ROCE(HY)

Lowest at -4.93%

RAW MATERIAL COST(Y)

Grown by 12.62% (YoY

INTEREST(Q)

Highest at CNY 3.59 MM

Here's what is working for Chongqing Lummy Pharmaceutical Co., Ltd.
Cash and Eqv
Highest at CNY 1,922.06 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Inventory Turnover Ratio
Highest at 1.83%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Here's what is not working for Chongqing Lummy Pharmaceutical Co., Ltd.
Net Profit
At CNY -75.16 MM has Grown at -283.27%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CNY MM)

Interest
At CNY 3.59 MM has Grown at 10.76%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Sales
At CNY 381 MM has Grown at -9.89%
Year on Year (YoY)
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Interest
Highest at CNY 3.59 MM
in the last five periods and Increased by 10.76% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Raw Material Cost
Grown by 12.62% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."